Micronization of meloxicam using a supercritical fluids process

被引:47
作者
Chiou, Andy Hong-Jey [1 ]
Yeh, Ming-Kung
Chen, Chang-Yi
Wang, Da-Peng
机构
[1] Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan
[2] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Pharm, Taipei, Taiwan
[3] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan
关键词
powder technology; particle size; micronized drug; supercritical fluid;
D O I
10.1016/j.supflu.2006.12.024
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 [物理化学]; 081704 [应用化学];
摘要
A pre-filtration rapid expansion of a supercritical solution (PF-RESS) technique was developed to reduce particle size and to increase drug solubility. Carbon dioxide was used as the supercritical fluid and meloxicam was employed as the model drug. The meloxicam content was measured using high-performance liquid chromatography (HPLC). The physicochemical properties of the micronized meloxicam, were assessed using scanning electron and optical microscopy, laser light scattering, and powder X-ray diffraction. No aggregation occurred and no polymorphism was observed in the micronized drug. The morphology of the micronized drug was irregular in shape, with a uniform particle size between 0.5 and 2 mu m. The micronized meloxicam solubility in water (7.9 mu g/mL) and the solubility rate (0.19 mu g/mL/min) after a period of 30 min were faster than non-micronized meloxicam (3.6 mu g/mL and 0.02 mu g/mL/min, respectively). Although no significant change in dissolution rate at pH 1.2 was observed between the micronized and non-micronized meloxicam, when the pH was increased to 5.0-7.4, the micronized meloxicam showed a significant increase in dissolution rate after a period of 180 min. Our results provide an alternative methodology for improving the solubility of poorly soluble drugs, and show this methodology's great potential in oral drug delivery systems. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:120 / 128
页数:9
相关论文
共 27 条
[1]
Baboota S, 2003, PHARMAZIE, V58, P73
[2]
Badens E, 2001, BIOTECHNOL BIOENG, V72, P194, DOI 10.1002/1097-0290(20000120)72:2<194::AID-BIT8>3.0.CO
[3]
2-L
[4]
Production of drug loaded microparticles by the use of supercritical gases with the aerosol solvent extraction system (ASES) process [J].
Bleich, J ;
Muller, BW .
JOURNAL OF MICROENCAPSULATION, 1996, 13 (02) :131-139
[5]
Chaumeil JC, 1998, METHOD FIND EXP CLIN, V20, P211
[6]
Tablet formulation containing meloxicam and β-cyclodextrin:: Mechanical characterization and Bioavailability evaluation -: art. no. 59 [J].
Ghorab, MM ;
Abdel-Salam, HM ;
El-Sayad, MA ;
Mekhel, MM .
AAPS PHARMSCITECH, 2004, 5 (04)
[7]
Physicochemical evaluation of carbamazepine microparticles produced by the rapid expansion of supercritical solutions and by spray-drying [J].
Gosselin, P ;
Lacasse, FX ;
Preda, M ;
Thibert, R ;
Clas, SD ;
McMullen, JN .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2003, 8 (01) :11-20
[8]
Polymorphic properties of micronized carbamazepine produced by RESS [J].
Gosselin, PM ;
Thibert, R ;
Preda, M ;
McMullen, JN .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 252 (1-2) :225-233
[9]
Melt extrusion -: an alternative method for enhancing the dissolution rate of 17β-estradiol hemihydrate [J].
Hülsmann, S ;
Backensfeld, T ;
Keitel, S ;
Bodmeier, R .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 49 (03) :237-242
[10]
Micronization of drugs using supercritical carbon dioxide [J].
Kerc, J ;
Srcic, S ;
Knez, Z ;
Sencar-Bozic, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 182 (01) :33-39